These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9882366)

  • 1. A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles.
    Von Seggern DJ; Chiu CY; Fleck SK; Stewart PL; Nemerow GR
    J Virol; 1999 Feb; 73(2):1601-8. PubMed ID: 9882366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
    Krougliak V; Graham FL
    Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
    Oualikene W; Lamoureux L; Weber JM; Massie B
    Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.
    Legrand V; Spehner D; Schlesinger Y; Settelen N; Pavirani A; Mehtali M
    J Virol; 1999 Feb; 73(2):907-19. PubMed ID: 9882291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells.
    Jakubczak JL; Rollence ML; Stewart DA; Jafari JD; Von Seggern DJ; Nemerow GR; Stevenson SC; Hallenbeck PL
    J Virol; 2001 Mar; 75(6):2972-81. PubMed ID: 11222722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
    Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
    Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
    Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
    J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
    Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
    J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.
    Von Seggern DJ; Huang S; Fleck SK; Stevenson SC; Nemerow GR
    J Virol; 2000 Jan; 74(1):354-62. PubMed ID: 10590124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin.
    Krasnykh V; Belousova N; Korokhov N; Mikheeva G; Curiel DT
    J Virol; 2001 May; 75(9):4176-83. PubMed ID: 11287567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.
    Schoggins JW; Falck-Pedersen E
    Virology; 2009 Dec; 395(1):10-20. PubMed ID: 19782383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.
    Stevenson SC; Rollence M; Marshall-Neff J; McClelland A
    J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient mobilization of E1-deleted adenovirus type 5 vectors by wild-type adenoviruses of other serotypes.
    Rademaker HJ; El Hassan MAA; Versteeg GA; Rabelink MJWE; Hoeben RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1311-1314. PubMed ID: 12029145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.
    Yeh P; Dedieu JF; Orsini C; Vigne E; Denefle P; Perricaudet M
    J Virol; 1996 Jan; 70(1):559-65. PubMed ID: 8523570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
    Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
    Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.
    Fallaux FJ; Kranenburg O; Cramer SJ; Houweling A; Van Ormondt H; Hoeben RC; Van Der Eb AJ
    Hum Gene Ther; 1996 Jan; 7(2):215-22. PubMed ID: 8788172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dependence of adenovirus infectivity on length of the fiber shaft domain.
    Shayakhmetov DM; Lieber A
    J Virol; 2000 Nov; 74(22):10274-86. PubMed ID: 11044071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
    Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
    J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
    Amalfitano A; Begy CR; Chamberlain JS
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner.
    Shayakhmetov DM; Li ZY; Gaggar A; Gharwan H; Ternovoi V; Sandig V; Lieber A
    J Virol; 2004 Sep; 78(18):10009-22. PubMed ID: 15331734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.